EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Arteriovenous Malformations (AVMs): Molecular Pathogenesis, Clinical Features, and Emerging Therapeutic Strategies

Nga Le iD, Yan Li, Gianni Walker iD, Bao-Ngoc Nguyen, Arash Bornak iD, Sapna K Deo, Omaida C Velazquez, Zhao-Jun Liu

Biomolecules · 27.11.2025 · 15 (12) · 1661

DOI: 10.3390/biom15121661 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 27.11.2025. Verfasst von Nga Le und 7 weiteren Autor:innen. Beteiligte Einrichtung: DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA. Hauptthemen laut MEDLINE: Arteriovenous Malformations. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health, Eloise & David Kimmelman Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arteriovenous malformations (AVMs) are fast-flow vascular malformations formed by direct artery-to-vein shunts without an intervening capillary bed, which increases the risk of hemorrhage and organ-specific damage. A synthesis of recent advances shows that AVMs arise from interplay between germline susceptibility (ENG, ACVRL1, SMAD4, RASA1, EPHB4), somatic mosaicism (KRAS, MAP2K1, PIK3CA), perturbed signaling (TGF-β/BMP, Notch, VEGF, PI3K/AKT, RAS/MAPK), hemodynamic stress, and inflammation. Multimodal imaging—digital subtraction angiography (DSA), MRI/MRA with perfusion and susceptibility sequences, CTA, Doppler ultrasound, and 3D rotational angiography—underpins diagnosis and risk stratification, while arterial spin labeling and 4D flow techniques refine hemodynamic assessment. Management is individualized and multidisciplinary, combining endovascular embolization, microsurgical resection, and stereotactic radiosurgery (SRS); a non-surgical approach and monitoring remain reasonable for some asymptomatic AVMs. Device and technique innovations (detachable-tip microcatheters, pressure-cooker approaches, and newer liquid embolics such as PHIL and Squid) have broadened candidacy, and precision-medicine strategies, including pathway-targeted pharmacotherapy, are emerging for syndromic and somatic-mutation–driven AVMs. Animal models and computational/radiomics tools increasingly guide hypothesis generation and treatment selection. We outline practical updates and future priorities: integrated genomic-imaging risk scores, genotype-informed medical therapy, rational hybrid sequencing, and long-term outcome standards focused on hemorrhage prevention and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous MalformationsHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

arteriovenous malformation (AVM)embolizationhereditary hemorrhagic telangiectasia (HHT)molecular signalingstereotactic radiosurgeryvascular diseases

Autor:innen und Institutionen

  • DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Biochemistry & Molecular Biology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Department of Surgery, The George Washington University School of Medicine, Washington, DC 20037, USA.
  • Department of Radiology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

ORCID-Profile: Nga Le, Gianni Walker, Arash Bornak

Förderung

  • NIH HHS
  • National Institutes of Health
  • Eloise & David Kimmelman Foundation

Zitieren

APA

Le, N., Li, Y., Walker, G., Nguyen, B. N., Bornak, A., Deo, S. K., Velazquez, O. C., & Liu, Z. J. (2025). Arteriovenous Malformations (AVMs): Molecular Pathogenesis, Clinical Features, and Emerging Therapeutic Strategies. Biomolecules, 15(12), 1661. https://doi.org/10.3390/biom15121661

Vancouver

Le N, Li Y, Walker G, Nguyen BN, Bornak A, Deo SK, et al. Arteriovenous Malformations (AVMs): Molecular Pathogenesis, Clinical Features, and Emerging Therapeutic Strategies. Biomolecules. 2025;15(12):1661. doi:10.3390/biom15121661

BibTeX
@article{Le2025,
  author = {Le, Nga and Li, Yan and Walker, Gianni and Nguyen, Bao-Ngoc and Bornak, Arash and Deo, Sapna K and Velazquez, Omaida C and Liu, Zhao-Jun},
  title = {Arteriovenous Malformations (AVMs): Molecular Pathogenesis, Clinical Features, and Emerging Therapeutic Strategies},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {12},
  pages = {1661},
  doi = {10.3390/biom15121661}
}
Kostenlos starten →